- Armata Pharmaceuticals press release (NYSE:ARMP): Q1 GAAP EPS of -$0.40.
- Revenue of $0.79M (-35.8% Y/Y).
Cash and Equivalents. As of March 31, 2023, Armata held approximately $25.1 million of unrestricted cash and cash equivalents, as compared to $14.9 million as of December 31, 2022.
As of May 5, 2023, there were approximately 36.1 million shares of common stock outstanding.
Armata Pharmaceuticals GAAP EPS of -$0.40, revenue of $0.79M
Recommended For You
More Trending News
About ARMP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ARMP | - | - |
Armata Pharmaceuticals, Inc. |